However, recent phase 3 clinical trials using nivolumab in unmethylated-MGMT GBM with radiotherapy and methylated-MGMT GBM with chemoradiotherapy did not show any improvement in OS and PFS [38]. The gene discussed is MGMT; the disease is glioblastoma.